{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:30:03Z","timestamp":1792287003769,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":466,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.7861\/clinmed.2022-0372","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T07:31:03Z","timestamp":1674631863000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists"],"prefix":"10.1016","volume":"23","author":[{"given":"Rippie K","family":"Tutika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Tatton-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Copson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed.2022-0372_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-genom-111919-082433","article-title":"Cultivating DNA Sequencing Technology After the Human Genome Project","volume":"21","author":"Schloss","year":"2020","journal-title":"Ann Rev Genomics Hum Genet"},{"key":"10.7861\/clinmed.2022-0372_bib2","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.1204040","article-title":"Exploring the genomes of cancer cells: progress and promise","volume":"331","author":"Stratton","year":"2011","journal-title":"Science"},{"key":"10.7861\/clinmed.2022-0372_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygeno.2015.11.003","article-title":"The sequence of sequencers: The history of sequencing DNA","volume":"107","author":"Heather","year":"2016","journal-title":"Genomics"},{"key":"10.7861\/clinmed.2022-0372_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/mutage\/geu031","article-title":"Next-generation sequencing technologies: breaking the sound barrier of human genetics","volume":"29","author":"Bahassi el","year":"2014","journal-title":"Mutagenesis"},{"key":"10.7861\/clinmed.2022-0372_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12920-017-0271-4","article-title":"Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing","volume":"10","author":"Cheng","year":"2017","journal-title":"BMC Med Genomics"},{"key":"10.7861\/clinmed.2022-0372_bib6","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/jcph.765","article-title":"Precision oncology medicine: the clinical relevance of patient-specific biomarkers used to optimize cancer treatment","volume":"56","author":"Schmidt","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.7861\/clinmed.2022-0372_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/GIM.0b013e3181afbaed","article-title":"Direct to consumer genetic testing: Avoiding a culture war","volume":"11","author":"Evans","year":"2009","journal-title":"Genet Med"},{"key":"10.7861\/clinmed.2022-0372_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature12981","article-title":"Realizing the promise of cancer predisposition genes","volume":"505","author":"Rahman","year":"2014","journal-title":"Nature"},{"key":"10.7861\/clinmed.2022-0372_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmed.2022-0372_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/bcr3332","article-title":"Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?","volume":"14","author":"Turner","year":"2012","journal-title":"Br Cancer Res"},{"key":"10.7861\/clinmed.2022-0372_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.19.02107","article-title":"Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164","volume":"38","author":"Le","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.7861\/clinmed.2022-0372_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.7861\/clinmed.2022-0372_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41591-018-0009-7","article-title":"Carboplatin in BRCA1\/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial","volume":"24","author":"Tutt","year":"2018","journal-title":"Nat Med"},{"key":"10.7861\/clinmed.2022-0372_bib14","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1- or BRCA2-Mutated Breast Cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmed.2022-0372_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.7861\/clinmed.2022-0372_bib16","unstructured":"16 Birmingham Women's and Children's NHS Foundation Trust. Information for professionals: Genetics. https:\/\/bwc.nhs.uk\/information-for-professionals-genetics\/."},{"key":"10.7861\/clinmed.2022-0372_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7861\/clinmedicine.14-4-436","article-title":"Mainstreaming genetic testing of cancer predisposition genes","volume":"14","author":"Rahman","year":"2014","journal-title":"Clin Med"},{"key":"10.7861\/clinmed.2022-0372_bib18","doi-asserted-by":"crossref","first-page":"e194428","DOI":"10.1001\/jamanetworkopen.2019.4428","article-title":"Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer","volume":"2","author":"Kemp","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.7861\/clinmed.2022-0372_bib19","unstructured":"19 Genetic Alliance,. NHS Genetic Services in the UK 2020. https:\/\/geneticalliance.org.uk\/information\/service-and-testing\/nhs-genetic-services-in-the-uk-2\/."},{"key":"10.7861\/clinmed.2022-0372_bib20","series-title":"Clinical Oncology - UK workforce census report 2018","year":"2018"},{"key":"10.7861\/clinmed.2022-0372_bib21","series-title":"Achieving world-class cancer outcomes: A strategy for England 2015-2020","year":"2016"},{"key":"10.7861\/clinmed.2022-0372_bib22","first-page":"CD001431","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.7861\/clinmed.2022-0372_bib23","doi-asserted-by":"crossref","first-page":"e030505","DOI":"10.1136\/bmjopen-2019-030505","article-title":"Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees","volume":"9","author":"Al Bakir","year":"2019","journal-title":"BMJ Open"},{"key":"10.7861\/clinmed.2022-0372_bib24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1186\/s12885-015-1934-1","article-title":"Understanding of BRCA VUS genetic results by breast cancer specialists","volume":"15","author":"Eccles","year":"2015","journal-title":"BMC Cancer"},{"key":"10.7861\/clinmed.2022-0372_bib25","unstructured":"25 SurveyMonkey: Momentive Inc.; 2022."},{"key":"10.7861\/clinmed.2022-0372_bib26","series-title":"ACP medical oncology training survey report 2019","year":"2019"},{"key":"10.7861\/clinmed.2022-0372_bib27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3332\/ecancer.2016.608","article-title":"An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients","volume":"10","author":"Baird","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"10.7861\/clinmed.2022-0372_bib28","unstructured":"28 Health Education England,. Genomics Education Programme. www.genomicseducation.hee.nhs.uk\/."},{"key":"10.7861\/clinmed.2022-0372_bib29","unstructured":"29 Health Education England,. GeNotes: genomic notes for clinicians. www.genomicseducation.hee.nhs.uk\/about-us\/genotes-genomic-notes-for-clinicians\/."},{"key":"10.7861\/clinmed.2022-0372_bib30","unstructured":"30 St George's University of London,. Interpreting genomic variation: inherited cancer susceptibility. www.futurelearn.com\/courses\/interpreting-genomic-variation-inherited-cancer-susceptibility."},{"key":"10.7861\/clinmed.2022-0372_bib31","unstructured":"31 Guy's and St Thomas' NHS Foundation Trust,. Virtual Cancer Genetics Course 2022. www.guysandstthomasevents.co.uk\/courses\/virtual-cancer-genetics-course-2022\/."},{"key":"10.7861\/clinmed.2022-0372_bib32","series-title":"UK Practice Guidelines for variant classification","author":"Ellard","year":"2020"},{"key":"10.7861\/clinmed.2022-0372_bib33","author":"CanVIG-UK","year":"2022","journal-title":"CanVIG-UK Resource Templates"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824046463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed.2022-0372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T17:59:44Z","timestamp":1746813584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824046463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1470211824046463"],"URL":"https:\/\/doi.org\/10.7861\/clinmed.2022-0372","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed.2022-0372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2023. All rights reserved.","name":"copyright","label":"Copyright"}]}}